These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 9715327)

  • 1. Hemostasis in acquired hemophilia--role of intracavitary instillation of EACA.
    Sahu S; Raipancholia R; Pardiwalla FK; Pathare AV
    J Postgrad Med; 1996; 42(3):88-90. PubMed ID: 9715327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired hemophilia.
    Bouvry P; Recloux P
    Haematologica; 1994; 79(6):550-6. PubMed ID: 7896216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New protocol for immune tolerance induction in acquired hemophilia.
    Nemes L; Pitlik E
    Haematologica; 2000 Oct; 85(10 Suppl):64-8. PubMed ID: 11187874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epsilon aminocaproic acid reduces transfusion requirements in patients with thrombocytopenic hemorrhage.
    Kalmadi S; Tiu R; Lowe C; Jin T; Kalaycio M
    Cancer; 2006 Jul; 107(1):136-40. PubMed ID: 16708357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recombinant factor VIIa (eptacog alfa): a new therapeutic option for patients with severe bleeding disorder due to inhibitory antibodies against a coagulation factor].
    Turkstra F; Levi M; Koopman MM; Wester JP; Stoutenbeek CP; Briët E
    Ned Tijdschr Geneeskd; 1998 Jun; 142(25):1464-7. PubMed ID: 9752060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporine treatment of acquired hemophilia due to factor VIII antibodies.
    Petrovic M; Derom E; Baele G
    Haematologica; 2000 Aug; 85(8):895-6. PubMed ID: 10942956
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety and efficacy of purified factor IX concentrate and antifibrinolytic agents for dental extractions in hemophilia B.
    Djulbegovic B; Marasa M; Pesto A; Kushner GM; Hadley T; Joseph G; Goldsmith G
    Am J Hematol; 1996 Feb; 51(2):168-70. PubMed ID: 8579061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current management of acquired factor VIII inhibitors.
    Barnett B; Kruse-Jarres R; Leissinger CA
    Curr Opin Hematol; 2008 Sep; 15(5):451-5. PubMed ID: 18695367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Macrohaematuria post-partum: an unusual case of acquired haemophilia after pregnancy].
    Prencipe MA; D'Errico M; Di Giorgio G; Gatta G; Gesuete A; Nobile M; Stallone C
    G Ital Nefrol; 2002; 19(2):204-8. PubMed ID: 12195420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tranexamic acid in the control of spontaneous bleeding in severe haemophilia.
    Rainsford SG; Jouhar AJ; Hall A
    Thromb Diath Haemorrh; 1973 Nov; 30(2):272-9. PubMed ID: 4773366
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anti-factor VIII antibodies in children with hemophilia, and the management of hemorrhage].
    Klukowska A; Adamowicz-Salach A; Kamińska D; Zieleniewska B
    Pol Tyg Lek; 1987 Jul; 42(30):911-4. PubMed ID: 3118341
    [No Abstract]   [Full Text] [Related]  

  • 12. [Tooth extraction in patients suffering from hemophilia A under the cover of cryoprecipitates and epsilon-aminocaproic acid].
    Pniejnia-Olszyński W; Pietrzykowska E; Lopaciuk S
    Acta Haematol Pol; 1979; 10(2):123-8. PubMed ID: 474045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of two patients with acquired factor VIII inhibitors using cyclophosphamide and prednisone.
    Hertzberg MS; Favaloro E; Koutts J
    Am J Hematol; 2002 Aug; 70(4):330-1. PubMed ID: 12210817
    [No Abstract]   [Full Text] [Related]  

  • 14. Epsilon-aminocaproic acid inhibits the activity of factor VIII inhibitors in patients with severe haemophilia A in vivo and in vitro.
    Ghosh K; Shetty S; Pathare A; Mohanty D
    Acta Haematol; 2000; 103(2):67-72. PubMed ID: 10838448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to factor VIII in hemophilia A patients.
    Brackmann HH; Schwaab R; Effenberger W; Hess L; Hanfland P; Oldenburg J
    Vox Sang; 2000; 78 Suppl 2():187-90. PubMed ID: 10938950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
    Santagostino E; Morfini M; Rocino A; Baudo F; Scaraggi FA; Gringeri A
    Thromb Haemost; 2001 Oct; 86(4):954-8. PubMed ID: 11686352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case report: successful use of antifibrinolytic therapy in acquired factor VIII deficiency.
    Lalwani RB; Stricker RB
    Am J Med Sci; 1992 Jun; 303(6):398-401. PubMed ID: 1605170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating antibodies in factor VIII deficiency hemophilia: report of case.
    Cudzinowski L
    ASDC J Dent Child; 1979; 46(1):54-6. PubMed ID: 283081
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical investigation on the effect of intravesical instillation of antifibrinolytic agents with bacillus Calmette-Guerin on preventing bladder cancer recurrence].
    Ding GQ; Shen ZJ; Lu J; Jin XD; Chen J; Shi SF
    Zhonghua Wai Ke Za Zhi; 2005 Nov; 43(22):1457-60. PubMed ID: 16318813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lingual hemorrhage in a patient with hemophilia A complicated by a high titer inhibitor. Management by continuous infusion of monoclonal antibody-purified factor VIII.
    Gordon EM; Mungo R; Goldsmith JC
    Am J Pediatr Hematol Oncol; 1993 Feb; 15(1):107-10. PubMed ID: 8447550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.